Grisanti Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Grisanti Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-870	Closed	-$39K	–	52
2019 Q2	$39K	Hold	870	–	–	0.02%	57
2019 Q1	$42K	Hold	870	–	–	0.03%	59
2018 Q4	$45K	Hold	870	–	–	0.03%	55
2018 Q3	$54K	Sell	870 -10,915	-93%	-$648K	0.03%	58
2018 Q2	$652K	Sell	11,785 -3,690	-24%	-$199K	0.28%	42
2018 Q1	$979K	Sell	15,475 -1,265	-8%	-$81.4K	0.45%	37
2017 Q4	$1.03M	Sell	16,740 -60	-0.4%	-$3.75K	0.42%	37
2017 Q3	$1.07M	Hold	16,800	–	–	0.44%	36
2017 Q2	$936K	Buy	16,800 +13,110	+355%	+$713K	0.4%	36
2017 Q1	$201K	Buy	3,690 +1,740	+89%	+$95.4K	0.08%	44
2016 Q4	$114K	Hold	1,950	–	–	0.05%	45
2016 Q3	$105K	Hold	1,950	–	–	0.05%	38
2016 Q2	$143K	Hold	1,950	–	–	0.08%	34
2016 Q1	$124K	Hold	1,950	–	–	0.06%	45
2015 Q4	$134K	Hold	1,950	–	–	0.06%	36
2015 Q3	$115K	Hold	1,950	–	–	0.05%	40
2015 Q2	$129K	Hold	1,950	–	–	0.05%	42
2015 Q1	$125K	Hold	1,950	–	–	0.05%	42
2014 Q4	$115K	Hold	1,950	–	–	0.04%	50
2014 Q3	$100K	Hold	1,950	–	–	0.04%	48
2014 Q2	$95K	Hold	1,950	–	–	0.04%	46
2014 Q1	$101K	Buy	+1,950	New	+$104K	0.04%	49

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Grisanti Capital Management's BMY Position: Q3 2019 in Review

Grisanti Capital Management sold out of Bristol-Myers Squibb (BMY) in Q3 2019, closing a stake of 870 shares — an estimated $39K sold.

Grisanti Capital Management first reported a position in BMY in Q1 2014 and held it in 22 quarters. The position peaked at $1.07M in Q3 2017. 1,815 funds tracked by Wall St. Rank hold BMY as of Q3 2019.

Grisanti Capital Management reported no remaining Bristol-Myers Squibb position as of Q3 2019 after selling out during the quarter.
Grisanti Capital Management sold 870 Bristol-Myers Squibb shares in Q3 2019, an estimated $39K.
Grisanti Capital Management first reported a position in Bristol-Myers Squibb in Q1 2014 and held it in 22 quarters.
Grisanti Capital Management's Bristol-Myers Squibb position peaked at $1.07M in Q3 2017.
1,815 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2019.

Based on Grisanti Capital Management's 13F filing for Q3 2019, filed 1 Nov 2019.